OTC Markets OTCQB - Delayed Quote USD

International Isotopes Inc. (INIS)

0.0400
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Shahe Bagerdjian President,CEO & Director 359.2k -- 1985
Mr. W. Matthew Cox B.S., CPA CFO & Secretary 147.94k -- 1984

International Isotopes Inc.

4137 Commerce Circle
Idaho Falls, ID 83401
United States
208 524 5300 https://www.intisoid.com
Sector: 
Healthcare
Full Time Employees: 
41

Description

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, or research applications. The Cobalt Products segment produces cobalt-60 products and services, the fabrication of cobalt-60 sealed sources for radiation therapy, industrial and medical applications, and recycling of expended cobalt-60 sources. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, cylinder phantoms, rod sources, line sources, flexible and rigid rulers,spot markers, pen point markers, and various specialty design items. The Medical Devices segment develops EasyFill Automated Capsule System, a robotic lab device. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.

Corporate Governance

International Isotopes Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 20, 2025 at 10:59 AM UTC - May 26, 2025 at 12:00 PM UTC

International Isotopes Inc. Earnings Date

Recent Events

April 30, 2025 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

March 4, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

November 12, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 16, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 21, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

May 15, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 29, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 29, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers